Table 3.
n=46 | G1 (%) | G2 (%) | G3 (%) | Total (%) |
Any adverse event | ||||
Fever | 10 (22) | 0 | 0 | 10 (22) |
Fatigue | 14 (30) | 3 (7) | 0 | 17 (37) |
Body weight loss | 6 (13) | 0 | 0 | 6 (13) |
Anorexia | 18 (39) | 12 (26) | 2 (4) | 32 (70) |
Nausea | 17 (37) | 12 (26) | 1 (2) | 30 (65) |
Vomiting | 5 (11) | 1 (2) | 0 | 6 (13) |
Constipation | 23 (50) | 1 (2) | 0 | 24 (52) |
Diarrhoea | 5 (11) | 1 (2) | 2 (4) | 8 (17) |
Stomatitis | 2 (4) | 0 | 0 | 2 (4) |
Febrile neutropaenia | 0 | 0 | 3 (7) | 3 (7) |
Alopecia | 6 (13) | 4 (9) | 0 | 10 (22) |
No G4 or severe adverse events were observed.